Inventor

BECKMANN M PATRICIA

US36 patents

⚠️ This page may combine multiple inventors who share the name “BECKMANN M PATRICIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BECKMANN M PATRICIA

IMMUNEX CORP

Method for suppressing inflammatory responses by administering TNFR

Antibodies that bind hek ligands

DNA encoding tumor necrosis factor-α and -β receptors

Antibodies to interleukin-4 receptors and uses thereof

DNA encoding tumor necrosis factor-α and -β receptors

DNA encoding interleukin-4 receptors

Methods of stimulating hematopoietic cells with flt3-ligand

Antibodies directed against elk ligand

Antibodies that are immunoreactive with interleukin-4 receptors

Interleukin-4 receptors

Antibodies to Interleukin-4 receptors and uses thereof

DNA encoding tumor necrosis factor-α and -β receptors

Interleukin-4 receptors

DNA encoding interleukin-4 receptors

Purified p75 (type II) tumor necrosis factor receptor polypeptides

DNA encoding interleukin-4 receptors

Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4

CD27 ligand

Ligands for flt3 receptors

DNA encoding cytokines that bind the cell surface receptor hek

Elk ligand fusion proteins

Cytokine designated elk ligand

Antibodies which specifically bind to TNF-R

Cytokines that bind the cell surface receptor hek

Antibodies against flt3-ligand

Methods of using Flt-3 ligand for exogenous gene transfer

Cytokine designated elk ligand

DNA encoding leukemia inhibitory factor receptors

Glycoproteins which bind to TNF

Cytokines that bind the cell surface receptor hek

Cytokines that bind the cell surface receptor Hek

Medium containing flt3 ligand for culturing hematophoietic cells

Methods of using flt3-ligand in hematopoietic cell transplantation

Ligands for flt3 receptors

(unassigned)

Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)

GENENTECH INC

Methods for using elk-L to enhance neuronal survival